Search results for "Cardiovascular risk"
New recommendations advise on adding SGLT-2 inhibitors and GLP-1 receptor agonists
A new guideline from The BMJ strongly recommends sodium-glucose cotransporter-2 (SGLT-2) inhibitors for patients with diabetes and established cardiovascular and chronic kidney disease, among other advice.
https://immattersacp.org/weekly/archives/2021/05/18/4.htm
18 May 2021
Keep a close eye on the kidneys in diabetes
Screening and adherence to best prescribing practices offer two key ways to prevent or slow the progression of chronic kidney disease in patients with diabetes.
https://immattersacp.org/archives/2020/09/keep-a-close-eye-on-the-kidneys-in-diabetes.htm
1 Sep 2020
Separate industry-funded studies find benefit to bempedoic acid as preventive medication, CRP as biomarker
Bempedoic acid reduced cardiovascular (CV) events among patients unwilling or unable to take statins, a trial found, while a review showed that high-sensitivity C-reactive protein (CRP) was a stronger predictor for risk of future CV events and death than cholesterol in patients on statins.
https://immattersacp.org/weekly/archives/2023/03/14/4.htm
14 Mar 2023
MKSAP Quiz: Follow-up for diabetes, hyperlipidemia, hypertension
A 68-year-old man is evaluated during a routine follow-up visit. Medical history is significant for type 2 diabetes mellitus, hyperlipidemia, hypertension, and aortofemoral bypass surgery 2 years ago. Following a physical exam, what is the most appropriate additional treatment?
https://immattersacp.org/weekly/archives/2022/11/15/3.htm
15 Nov 2022
Preventive aspirin inflames opinions
Aspirin's long-standing role in cardiovascular health does not resolve its precise benefit in terms of cardiovascular prevention, specifically in patients who haven't had a myocardial infarction or stroke.
https://immattersacp.org/archives/2015/05/aspirin.htm
1 May 2015
Stopping renin-angiotensin system inhibitors in advanced CKD did not appear to affect eGFR
A randomized open-label trial in the United Kingdom found that withdrawal of angiotensin-converting enzyme inhibitors and angiotensin-receptor blockers in patients with advanced chronic kidney disease (CKD) did not affect estimated glomerular filtration rate (eGFR).
https://immattersacp.org/weekly/archives/2022/11/08/2.htm
8 Nov 2022
Lessons from an outbreak
This issue also covers preexposure prophylaxis for HIV, adult survivors of congenital heart disease, and age-friendly geriatric care.
https://immattersacp.org/archives/2020/03/lessons-from-an-outbreak.htm
1 Mar 2020
MKSAP Quiz: Treatment of elevated cholesterol levels
A 58-year-old man is evaluated during a routine visit. He has psoriatic arthritis and hypertension. Following a physical exam and lab studies, what is the most appropriate treatment?
https://immattersacp.org/weekly/archives/2021/12/14/3.htm
14 Dec 2021
Pressing forward with primary prevention for CVD
This issue includes stories on managing cardiovascular disease, prescribing benzodiazepines, and diagnosing depression in the elderly.
https://immattersacp.org/archives/2022/02/pressing-forward-with-primary-prevention-for-cvd.htm
1 Feb 2022
MKSAP Quiz: Follow-up for stable chronic kidney disease
A 57-year-old man is evaluated during follow-up for stable chronic kidney disease diagnosed 1 year ago. He also has type 2 diabetes mellitus, hyperlipidemia, and peripheral artery disease. On physical examination, blood pressure is 128/74 mm Hg, pulse rate is 65/min, and respiration rate is 18/min. Bilateral carotid and lower abdominal quadrant bruits are heard. Peripheral extremity pulses are diminished. The remainder of the examination is normal. After laboratory studies, what is the appropriate management?
https://immattersacp.org/weekly/archives/2021/11/09/3.htm
9 Nov 2021